MoneyWorks4Me

Neuland Laboratories - Quaterly Results

01 Aug 2024 Evaluate
A fair growth of 21.10% in the revenue at Rs. 4396.02 millions was reported in the June 2024 quarter as compared to Rs. 3629.94 millions during year-ago period.Net profit surges 58.04% to Rs. 983.39  millions  from Rs. 622.24 millions in the quarter ended June 2024.Operating Profit saw a handsome growth to 1286.33 millions from 993.04 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 4396.02 3629.94 21.10 4396.02 3629.94 21.10 15585.80 11911.98 30.84
Other Income 48.07 20.39 135.75 48.07 20.39 135.75 125.44 97.48 28.68
PBIDT 1286.33 993.04 29.53 1286.33 993.04 29.53 4744.65 2810.56 68.82
Interest 26.71 22.14 20.64 26.71 22.14 20.64 139.97 130.67 7.12
PBDT 1465.88 970.90 50.98 1465.88 970.90 50.98 4604.68 2679.89 71.82
Depreciation 162.79 135.86 19.82 162.79 135.86 19.82 596.99 527.76 13.12
PBT 1303.09 835.04 56.05 1303.09 835.04 56.05 4007.69 2152.13 86.22
TAX 319.70 212.80 50.23 319.70 212.80 50.23 1011.73 520.94 94.21
Deferred Tax 13.89 3.33 317.12 13.89 3.33 317.12 15.87 17.04 -6.87
PAT 983.39 622.24 58.04 983.39 622.24 58.04 2995.96 1631.19 83.67
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 29.26 27.36 6.96 29.26 27.36 6.96 30.44 23.59 29.02
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..